Overviews of systematic reviews are a relatively new approach to synthesising evidence, and research methods and associated guidance are developing.
In this webinar Professor Ruth Hancock analyses the market for care homes for older people using Care Quality Commission and other data.
With Pfizer shutting down its neuroscience unit and a long list of failed late-stage trials, the sheer difficulty of improving the treatment of Alzheimer’s disease has become painfully clear. How can researchers crack the mystery of this much-feared neurodegenerative disease?
This review, aims to assess the ability of CSF tau biomarkers (t-tau and p-tau) and the CSF tau (t-tau or p-tau)/ABeta ratio to enable the detection of Alzheimer’s disease pathology in patients with mild cognitive impairment (MCI).
For many years people with dementia have been prescribed anti-psychotic drugs to manage challenging behaviours and agitation. Even today the reliance on this medication is too high, however, attitudes have changed, and over the past 5 years or more there had been a drive to reduce the use of these medications. However, that left the…
https://www.alzforum.org/news/research-news/does-daytime-drowsiness-foreshadow-av-accumulation
A large body of research has tied traumatic brain injuries to an increased risk for neurodegenerative disease, but many questions remained.
Anna Volkmer is a NIHR Doctoral Fellow at University College London, in her blog she discusses her work to develop a new speech and language therapy intervention for people with language led dementia.
Paul Brownbill, is from the University of South Wales, in his blog he talks about ‘Quality of Life and the Role of Communal Space in Sheltered Housing’
Editor
